Health‐related quality of life after open transhiatal and transthoracic oesophagectomy for cancer. BJS 2018; 105: 230-236.
Published: 5th February 2018
Authors: J. H. Kauppila, A. Johar, J. A. Gossage, A. R. Davies, J. Zylstra, J. Lagergren et al.
Transhiatal and transthoracic oesophagectomy in patients with oesophageal cancer have similar survival rates. Whether these approaches differ in health‐related quality of life (HRQoL) is uncertain and was examined in this study.
Patients undergoing transhiatal or transthoracic surgery for lower‐third oesophageal or gastro‐oesophageal junctional cancer between 2011 and 2015 were selected from an institutional database. HRQoL outcomes were measured at 6 and 12 months after surgery using validated written questionnaires (European Organisation for Research and Treatment of Cancer QLQ‐C30 and QLQ‐OG25). Linear mixed models provided mean score differences (MSDs) with 95 per cent confidence intervals, adjusted for preoperative HRQoL, age, physical status (ASA fitness grade), tumour location, tumour stage, neoadjuvant therapy, adjuvant therapy and postoperative complications. MSD values of 10 or more were regarded as clinically relevant.
Some 146 patients underwent transhiatal (86, 58·9 per cent) or transthoracic (60, 41·1 per cent) oesophagectomy. The HRQoL questionnaires were returned by 111 patients at 6 months and 74 at 12 months. At 6 months, transthoracic oesophagectomy was associated with worse role function (MSD –12, 95 per cent c.i. –23 to 0;
Transhiatal oesophagectomy seems to offer better HRQoL than transthoracic oesophagectomy 6 and 12 months after surgery.Read more
You may also be interested in
[18F]Fluorodeoxyglucose PET/CT and prediction of histopathological response to neoadjuvant chemotherapy for adenocarcinoma of the oesophagus and oesophagogastric junction.
Authors: T. Harustiak, M. Zemanova, P. Fencl, L. Hornofova, A. Pazdro, M. Snajdauf et al.
Notes: Of no use
Meta‐analysis of delayed gastric emptying after pylorus‐preserving versus pylorus‐resecting pancreatoduodenectomy.
Authors: U. Klaiber, P. Probst, O. Strobel, C. W. Michalski, C. Dörr‐Harim, M. K. Diener et al.
Notes: No difference
Intrathoracic versus cervical anastomosis and predictors of anastomotic leakage after oesophagectomy for cancer.
Authors: J. A. H. Gooszen, L. Goense, S. S. Gisbertz, J. P. Ruurda, R. van Hillegersberg, M. I. van Berge Henegouwen et al.
Notes: Chest lower leak rates
Meta‐analysis of metabolic surgery versus medical treatment for microvascular complications in patients with type 2 diabetes mellitus. BJS 2018; 105: 168-181.
Authors: A. T. Billeter, K. M. Scheurlen, P. Probst, S. Eichel, F. Nickel, S. Kopf et al.
Notes: Surgery is better
Outcomes after prophylactic gastrectomy for hereditary diffuse gastric cancer. BJS 2018; 105: e176-e182.
Authors: R. T. van der Kaaij, J. P. van Kessel, J. M. van Dieren, P. Snaebjornsson, O. Balagué, F. van Coevorden et al.
Notes: Frozen section of margins is key
Circulating tumour cells and DNA as liquid biopsies in gastrointestinal cancer. BJS 2018; 105: e110-e120.
Authors: O. Nordgård, K. Tjensvoll, B. Gilje, K. Søreide
Notes: The inner space frontier
Patient‐derived organoid models help define personalized management of gastrointestinal cancer. BJS 2018; 105: e48-e60.
Authors: M. R. Aberle, R. A. Burkhart, H. Tiriac, S. W. M. Olde Damink, C. H. C. Dejong, D. A. Tuveson et al.
Notes: Accelerating the science of personal care
Meta‐analysis of the prognostic value of CpG island methylator phenotype in gastric cancer. BJS 2018; 105: e61-e68.
Authors: A. G. M. T. Powell, S. Soul, A. Christian, W. G. Lewis
Notes: Heterogeneity in gene panels used
Authors: K. Boye, J.‐M. Berner, I. Hompland, Ø. S. Bruland, S. Stoldt, K. Sundby Hall et al.
Notes: Handle with care
Comparison of gaze behaviour of trainee and experienced surgeons during laparoscopic gastric bypass. BJS 2018; 105: 287-294.
Authors: S. Erridge, H. Ashraf, S. Purkayastha, A. Darzi, M. H. Sodergren
Notes: Potential uses in training and assessment
Impact of weight loss and eating difficulties on health‐related quality of life up to 10 years after oesophagectomy for cancer.
Authors: P. Anandavadivelan, A. Wikman, A. Johar, P. Lagergren
Notes: Associated with deterioration of HRQOL
Influence of national centralization of oesophagogastric cancer on management and clinical outcome from emergency upper gastrointestinal conditions. BJS 2018; 105: 113-120.
Authors: S. R. Markar, H. Mackenzie, T. Wiggins, A. Askari, A. Karthikesalingam, O. Faiz et al.
Notes: Improves outcome of oesophageal perforation